The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 67 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Adenocarcinoma  [Clear All Filters]
2020
Papaefthymiou, A., Doulberis M., Polyzos S. A., Katsinelos P., & Kountouras J. (2020).  Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma.. Aliment Pharmacol Ther. 51(11), 1215-1216.
2019
Paramythiotis, D., Goulas P., Moysidis M., Karakatsanis A., Tzioufa-Asimakopoulou V., Sotiriou S., et al. (2019).  Metachronous Ovarian Metastases in a Patient with Primary Colorectal Cancer. A Case Report and Review of the Literature.. Am J Case Rep. 20, 1515-1520.
2018
Kountouras, J., Doulberis M., Polyzos S. A., Zeglinas C., Vardaka E., Kountouras C., et al. (2018).  Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence.. Am J Gastroenterol. 113(11), 1723-1724.
2017
Kountouras, J., Polyzos S. A., Zeglinas C., Tzathas C., Nikolaidis N., Vardaka E., et al. (2017).  Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort.. Gastrointest Endosc. 85(2), 462-463.
Gkika, E., Adebahr S., Kirste S., Schimek-Jasch T., Wiehle R., Claus R., et al. (2017).  Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.. Strahlenther Onkol. 193(6), 433-443.
2016
Cohen, S. A., Wu C., Yu M., Gourgioti G., Wirtz R., Raptou G., et al. (2016).  Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.. Clin Colorectal Cancer. 15(2), 164-9.
Kountouras, J., Polyzos S. A., Zeglinas C., Katsinelos P., Giorgakis N., Vardaka E., et al. (2016).  Helicobacter pylori infection and oesophageal adenocarcinoma.. Cancer Epidemiol. 42, 206-7.
Mogoanta, S. Stefanita, Calotă F., Vasile I., Crafciuc A. Valentina, Gherghinescu M. Constantin, Sapalidis K., et al. (2016).  Histological and immunohistochemical study on sentinel lymph node in colorectal cancer - values and limitations.. Rom J Morphol Embryol. 57(1), 65-74.
Deshpande, V., Konstantinidis I. T., Del Castillo C. Fernandez-, Hezel A. F., Haigis K. M., Ting D. T., et al. (2016).  Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.. J Gastrointest Surg. 20(5), 953-9.
2015
Michalopoulos, N., Laskou S., Papadakis Y., Karayannopoulou G., & Kanellos I. (2015).  Anaplastic adenocarcinoma of the pancreas.. J Gastrointest Cancer. 46(1), 68-73.
Pentheroudakis, G., Raptou G., Kotoula V., Wirtz R. M., Vrettou E., Karavasilis V., et al. (2015).  Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.. PLoS One. 10(5), e0124612.
Casimiro, M. C., Di Sante G., Crosariol M., Loro E., Dampier W., Ertel A., et al. (2015).  Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis.. Oncotarget. 6(11), 8525-38.
Giannou, A. D., Marazioti A., Spella M., Kanellakis N. I., Apostolopoulou H., Psallidas I., et al. (2015).  Mast cells mediate malignant pleural effusion formation.. J Clin Invest. 125(6), 2317-34.
Zarogoulidis, P., Petanidis S., Kioseoglou E., Domvri K., Anestakis D., & Zarogoulidis K. (2015).  MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.. Cell Signal. 27(8), 1576-88.
Saridaki, Z., Lambrodimou G., Kachris S., Makrantonakis P., Boukovinas I., Polyzos A., et al. (2015).  Postoperative treatment with docetaxel, cisplatin, and capecitabine (DCX) and chemoradiotherapy (CRT) with capecitabine for resected gastric adenocarcinoma.. Am J Clin Oncol. 38(1), 17-22.
2014
Kalogiannidis, I., Petousis S., Bobos M., Margioula-Siarkou C., Topalidou M., Papanikolaou A., et al. (2014).  HER-2/neu is an independent prognostic factor in type I endometrial adenocarcinoma.. Arch Gynecol Obstet. 290(6), 1231-7.
Galimberti, V., Manika A., Maisonneuve P., Corso G., L Moltrasio S., Intra M., et al. (2014).  Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease.. Eur J Surg Oncol. 40(10), 1203-8.
Gargalionis, A. N., Karamouzis M. V., & Papavassiliou A. G. (2014).  The molecular rationale of Src inhibition in colorectal carcinomas.. Int J Cancer. 134(9), 2019-29.
Svoronos, C., Tsoulfas G., Katsourakis A., Noussios G., Chatzitheoklitos E., & N Marakis G. (2014).  Role of extended lymphadenectomy in the treatment of pancreatic head adenocarcinoma: review and meta-analysis.. ANZ J Surg. 84(10), 706-11.
Luther, B., von Lilien-Waldau V., Mamopoulos A., Katoh M., Friedrich M., Weinknecht S., et al. (2014).  [Ureteroarterial fistula - pathogenesis, diagnostics, and therapeutic outcome].. Aktuelle Urol. 45(3), 204-8.
2013
Pentheroudakis, G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., Makatsoris T., et al. (2013).  Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.. BMC Cancer. 13, 49.
Tsoulfas, G. (2013).  Blockade of chloride ion transport enhances the cytocidal effect of hypotonic solution in gastric cancer cells.. J Surg Res. 179(1), e49-50.
Pentheroudakis, G., Spector Y., Krikelis D., Kotoula V., Meiri E., Malamou-Mitsi V., et al. (2013).  Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.. Clin Exp Metastasis. 30(4), 431-9.
Martin, V., Landi L., Molinari F., Fountzilas G., Geva R., Riva A., et al. (2013).  HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients.. Br J Cancer. 108(3), 668-75.
Strimpakos, A., Pentheroudakis G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., et al. (2013).  The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.. Clin Colorectal Cancer. 12(4), 267-274.e2.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.